Navigation Links
Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
Date:6/10/2008

SOUTHAMPTON, Pa., June 10 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (Amex: ETC) ("ETC" or the "Company") BioMedical Systems division today announced the sale of seven (7) BARA-MED(R) XD Monoplace Hyperbaric Chambers to Med One Capital for placement at four (4) facilities associated with Haelen Hyperbarics.

ETC is delighted to work with Haelen Hyperbarics, a growing network of physician operated Hyperbaric Oxygen Therapy (HBOT) clinics. Haelen Hyperbarics also provides physicians with turn-key HBOT solutions to incorporate the therapy into their existing medical practices throughout the United States.

ETC prides itself on being the only manufacturer of a computerized monoplace hyperbaric chamber. The BARA-MED(R) XD includes a 4th generation Windows(TM) based operating system. This computerized system eliminates the need for operator dive time management and paper recordkeeping while ensuring comprehensive and unassailable documentation of the procedure. These features enable technicians to focus their attention on patient care and management, making them more effective and efficient.

Don Webber of ETC's BioMedical Division commented, "We are encouraged with the sales we have experienced during our 1st fiscal quarter."

The BioMedical Division continues to evolve its HBOT applications. The BARA-MED and BARA-MED XD are examples of ETC's ability to combine practical value with state-of-the-art technology.

For further information on ETC hyperbaric chambers and how our chambers could benefit your HBOT (Hyperbaric Oxygen Therapy) programs please visit our website http://www.etcbiomedical.com.

ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.

This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC's and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) the proposed acquisition of the Company by Lenfest, a member of ETC's Board of Directors and a significant shareholder, (ii) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, including our outstanding litigation with Disney; (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10-K, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

Contact: Duane D. Deaner, CFO

Tel: 215-355-9100 (ext. 1203)

Fax: 215-357-4000

ETC -- Internet Home Page: http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
2. Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico
3. Citrate appears to control buckyball clumping but environmental concerns remain
4. Environmental Power Announces Opening of New Corporate Headquarters in Tarrytown, NY
5. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
6. White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories
7. Nanotechs health, environmental impacts worry scientists and the public
8. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
9. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
10. Environmental Tectonics Corporations BioMedical Division Announces New Contract
11. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... The Real Dirt ... premier cannabis technology and application experts, Chip Baker. Chip Baker formerly co-founded Royal ... the past 30 years, Chip Baker other industry veterans have made the evolution ...
(Date:12/5/2016)... CHICAGO , December 5, 2016 ... report, "Cell Expansion Market, by Products (Consumable, Instruments, ... Applications (Regenerative Medicine and Stem Cell Research, Cancer, ... Research Institutes, Cell Banks) - Global Revenue, Trends, ... by Scalar Market Research, the global cell expansion ...
(Date:12/5/2016)... - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) ... Monitoring Board (DSMB) for the Company,s Phase 3 ... has completed a second planned safety review and ... without any modifications. The DSMB reviewed available study ... concerns were identified. The DSMB will conduct additional ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
Breaking Biology Technology:
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):